Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kris Giaya

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The American Journal of Tropical Medicine and Hygiene|November 15, 2012
Dengue virus type 2 modulates endothelial barrier function through CD73Chinmay Patkar, Kris Giaya, Daniel H Libraty
Biomedica : Revista Del Instituto Nacional De Salud|June 30, 2011
[Comparison of the transcriptional profiles of patients with dengue fever and dengue hemorrhagic fever reveals differences in the immune response and clues in immunopathogenesis]Natalia Houghton-Triviño, Katherine Martín, Kris Giaya, et al.
Journal of Virology|October 5, 2007
TRAIL is a novel antiviral protein against dengue virusRajas V Warke, Katherine J Martin, Kris Giaya, et al.
The Journal of General Virology|June 19, 2008
Efficient dengue virus (DENV) infection of human muscle satellite cells upregulates type I interferon response genes and differentially modulates MHC I expression on bystander and DENV-infected cellsRajas V Warke, Aniuska Becerra, Agatha Zawadzka, et al.
Plos One|February 18, 2014
Low adiposity during early infancy is associated with a low risk for developing dengue hemorrhagic fever: a preliminary modelDaniel H Libraty, Lei Zhang, Marcia Woda, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The American Journal of Tropical Medicine and Hygiene|November 15, 2012
Dengue virus type 2 modulates endothelial barrier function through CD73Chinmay Patkar, Kris Giaya, Daniel H Libraty
Biomedica : Revista Del Instituto Nacional De Salud|June 30, 2011
[Comparison of the transcriptional profiles of patients with dengue fever and dengue hemorrhagic fever reveals differences in the immune response and clues in immunopathogenesis]Natalia Houghton-Triviño, Katherine Martín, Kris Giaya, et al.
Journal of Virology|October 5, 2007
TRAIL is a novel antiviral protein against dengue virusRajas V Warke, Katherine J Martin, Kris Giaya, et al.
The Journal of General Virology|June 19, 2008
Efficient dengue virus (DENV) infection of human muscle satellite cells upregulates type I interferon response genes and differentially modulates MHC I expression on bystander and DENV-infected cellsRajas V Warke, Aniuska Becerra, Agatha Zawadzka, et al.
Plos One|February 18, 2014
Low adiposity during early infancy is associated with a low risk for developing dengue hemorrhagic fever: a preliminary modelDaniel H Libraty, Lei Zhang, Marcia Woda, et al.
Pageof 1